EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A possible turning point for research governance in the life sciences

David R Gillum iD

mSphere · 2025

DOI: 10.1128/msphere.00407-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mSphere, 2025. Verfasst von David R Gillum. Beteiligte Einrichtung: University of Nevada Reno, Compliance and Research Administration, Reno, Nevada, USA. Hauptthemen laut MEDLINE: Biological Science Disciplines, Containment of Biohazards, Biomedical Research. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

On 5 May 2025, the White House issued Executive Order (EO) 14292, halting federally funded “dangerous gain-of-function” research and rescinding the 2024 Dual Use Research of Concern (DURC) and Pathogens with Enhanced Pandemic Potential (PEPP) policy. While intended to strengthen biosafety and biosecurity, the EO introduces vague definitions, an abrupt 120-day policy development deadline, and politically charged rhetoric that could undermine trust and buy-in. Researchers, biosafety professionals, and institutions are left with a biosecurity policy vacuum after this EO, which is creating uncertainty across the scientific enterprise. This perspective considers the EO’s implications through empirical findings and practitioner insight and argues for a tiered, adaptive risk governance model grounded in scientific rigor, operational clarity, and institutional expertise to navigate future biosecurity challenges.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biological Science DisciplinesContainment of BiohazardsBiomedical ResearchHumansPandemics

Stichwörter der Autor:innen

DURCPEPPU.S. Policyadaptive risk governancebiosafetybiosecurityexecutive ordergain-of-functionvirology

Autor:innen und Institutionen

  • University of Nevada Reno, Compliance and Research Administration, Reno, Nevada, USA.

ORCID-Profile: David R Gillum

Förderung

  • NIGMS NIH HHS

Zitieren

APA

Gillum, D. R. (2025). A possible turning point for research governance in the life sciences. mSphere. https://doi.org/10.1128/msphere.00407-25

Vancouver

Gillum DR. A possible turning point for research governance in the life sciences. mSphere. 2025. doi:10.1128/msphere.00407-25

BibTeX
@article{Gillum2025,
  author = {Gillum, David R},
  title = {A possible turning point for research governance in the life sciences},
  journal = {mSphere},
  year = {2025},
  doi = {10.1128/msphere.00407-25}
}
Kostenlos starten →